Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New salts of known antimigraine agent from Glaxo Wellcome

March 24, 1997

5-HT1A antagonists from American Home Products

March 24, 1997

Glaxo Wellcome discloses cGMP-PDE inhibitors

March 24, 1997

SCRAS describes galanthamine derivatives

March 24, 1997

Pharmacia & Upjohn prepares stereoisomers of FCE-28260

March 24, 1997

Nippon Shinyaku discloses cell adhesion inhibitors

March 21, 1997

Cell migration inhibitors from Teijin

March 21, 1997

New cephalosporins from Kyoto Pharmaceutical Industries

March 21, 1997

Sagami prepares angiotensin IV agonists

March 21, 1997

Immunostimulants from Takeda

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.